Siga Technologies INC Deferred State and Local Income Tax Expense (Benefit)
Siga Technologies INC (SIGA) reported Deferred State and Local Income Tax Expense (Benefit) of $3.17 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-10
- Siga Technologies INC deferred state and local income tax expense (benefit) for fiscal 2025 was $3.17K.
- Siga Technologies INC deferred state and local income tax expense (benefit) for fiscal 2024 was -$100.61K.
- Siga Technologies INC deferred state and local income tax expense (benefit) for fiscal 2023 was -$86.18K.
- Siga Technologies INC deferred state and local income tax expense (benefit) for fiscal 2022 was -$9.49K, a 130.14% decline from fiscal 2021.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $3.17K 10-K · filed 2026-03-10 |
| 2024-12-31 | -$100.61K 10-K · filed 2026-03-10 |
| 2023-12-31 | -$86.18K 10-K · filed 2026-03-10 |
| 2022-12-31 | -$9.49K 10-K · filed 2025-03-11 |
| 2021-12-31 | $31.50K 10-K · filed 2024-03-12 |
| 2020-12-31 | $230.99K 10-K · filed 2023-03-02 |
| 2019-12-31 | -$325.03K 10-K · filed 2022-03-03 |
| 2018-12-31 | -$44.76K 10-K · filed 2021-03-04 |
| 2017-12-31 | $6.34K 10-K · filed 2020-03-05 |
| 2016-12-31 | -$829.00 10-K · filed 2019-03-06 |
| 2015-12-31 | $2.10K 10-K · filed 2018-03-06 |
| 2014-12-31 | $370.44K 10-K · filed 2017-03-07 |
| 2013-12-31 | $472.57K 10-K · filed 2016-03-04 |
| 2012-12-31 | -$290.64K 10-K · filed 2015-03-06 |
| 2011-12-31 | -$558.66K 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |